Captor Therapeutics SA Sustainability Reports
Captor Therapeutics S.A. is a biopharmaceutical company leveraging Targeted Protein Degradation (TPD) technology to discover and develop breakthrough therapeutics. The company focuses on developing novel small-molecule drugs for high unmet medical needs in cancer and autoimmune diseases.
Sector: Professional & technical services
Country: Poland
Exchange: Warsaw Stock Exchange
LEI: 259400JHH1S2I2S4O735
FIGI: BBG00XJCMKY4
1 reports from 2025 to 2025
